Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease.
about
Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatmentThe Human Experience with Intravenous LevodopaSuppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction.Continuous drug delivery in Parkinson's disease.Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression.Is striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia?The response to levodopa in Parkinson's disease: imposing pharmacological law and order.Continuous levodopa for advanced Parkinson's disease.Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease.Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats.
P2860
Q24647141-A34001EA-7446-42E7-980E-8A7B52474786Q26771516-2B855C23-BD03-414E-B06C-2464FD302B9EQ30465807-6807C7CB-1240-4622-BF09-10CFE6CA2600Q34390800-A2EC45A9-37EC-419C-9A6D-7B2B8ECCDC1EQ37924626-9C72E5D8-344F-4310-8374-7A7CDCF71295Q40980387-8F44989F-B8B1-4D63-80FC-CDA6C1F966D1Q40981288-006EB736-2C4F-4FAA-9FD0-6F84E80DAD29Q41825026-B0CE67A7-18D0-4738-A9F4-8ECDFB27CEC8Q43693354-84C0ED3F-8C8E-4BA0-BF82-59176BFCB0CBQ44423669-CDF275ED-B970-43E2-8304-73DA5577745EQ45076682-C94108A1-6FE0-4AFB-AEE4-F9F9778353D5Q48717596-C1E33538-92AF-46CF-8DAB-64F961305DCDQ54328579-17DA6BE0-1AEC-4288-A6A2-914807664AA9
P2860
Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease.
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Suppression of dyskinesias in ...... advanced Parkinson's disease.
@ast
Suppression of dyskinesias in ...... advanced Parkinson's disease.
@en
type
label
Suppression of dyskinesias in ...... advanced Parkinson's disease.
@ast
Suppression of dyskinesias in ...... advanced Parkinson's disease.
@en
prefLabel
Suppression of dyskinesias in ...... advanced Parkinson's disease.
@ast
Suppression of dyskinesias in ...... advanced Parkinson's disease.
@en
P921
P356
P1433
P1476
Suppression of dyskinesias in ...... advanced Parkinson's disease.
@en
P2093
Bennett JP Jr
P304
P356
10.1212/WNL.43.8.1545
P407
P577
1993-08-01T00:00:00Z